Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about DMT Clinical Trial Recent news which mentions DMT Clinical Trial Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results January 09, 2024 Tickers CYBN NEWS Tags Deuterated Psychedelics DMT Clinical Trial Benzinga From Benzinga Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics October 23, 2023 Tickers CYBN DMTTF Tags Psychedelics Benzinga DMT Clinical Trial From Benzinga Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation October 03, 2023 Tickers ATAI Tags treatment/resistant depression Market News Cannabis From Benzinga Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression September 26, 2023 Tickers CYBN Tags Penny Stocks News Guidance From Benzinga Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results September 26, 2023 Tickers CYBN DMTTF Tags Psychedelics Benzinga DMT Clinical Trial From Benzinga Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety August 28, 2023 Tickers CYBN DMTTF Tags Psychedelic/Assisted Therapies Short/Acting Psychedelics CYBN From Benzinga Cybin Launches 3-Day Overnight Public Offering For Up To $8.25M, Suspends Prior Purchase Deal August 01, 2023 Tickers CYBN IPOS Tags Financing CYBN IPOs From Benzinga DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up June 05, 2023 Tickers AGNPF Tags Management Psychedelic/Assisted Therapies Human Stroke From Benzinga Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes May 24, 2023 Tickers CYBN Tags DMT Entities Markets CYBN From Benzinga Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials May 11, 2023 Tickers ATAI CMPS Tags financials Guidance ATAI From Benzinga This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage December 22, 2022 Tickers DMTTF Tags Psychedelics Benzinga DMT Clinical Trial From Benzinga Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon November 16, 2022 Tickers AGNPF Tags DMT Clinical Trial Psychedelics Benzinga From Benzinga Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial November 04, 2022 Tickers BMNDF Tags Treatment Resistant Depression BMNDF DMT Clinical Trial From Benzinga Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University October 24, 2022 Tickers AGNPF Tags Markets AGNPF Market News From Benzinga atai's Phase 1 Synthetic DMT-Based Drug Clinical Trial Begins Patient Dosing October 05, 2022 Tickers ATAI Tags treatment/resistant depression Small Cap Market News From Benzinga Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage September 23, 2022 Tickers BMNDF Tags DMT Clinical Trial BMNDF Benzinga From Benzinga A Deeper Look At DMT Trials & Studies June 14, 2022 Tickers DMT Tags DMT contributors Benzinga From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.